Medical Director, Mood & Pipeline – US Medical Affairs

At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, and solutions are personal.

Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at  As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Medical Affairs Group

Medical Affairs

People Leader

Titusville, New Jersey, United States of America

• Lead the overarching medical portfolio and pipeline strategy across the Mood therapeutic area, including new-indication and label-expansion strategy for approved and pipeline assets.
• Provide medical leadership for new products and emerging assets in the Mood space, partnering with R&D and Global Medical Affairs from early development through launch.
• Own the portfolio-level data dissemination plan and congress strategy, ensuring a coherent scientific narrative across assets.
• Provide US medical input into Research & Development (R&D), including input into the design of R&D clinical trials, presentations and publications.
• Serve as the mechanism and emerging-science lead for the portfolio, and maintain ongoing competitive and scientific landscape surveillance (competitive intelligence) to inform strategy.
• Contribute as US MAF representative to supported lifecycle and new-indication studies including Phase IIIb/IV trials, post-marketing requirement studies, registries, real‑world evidence, and investigator‑initiated or collaborative studies leading study design, protocol development, analysis‑plan development, and overall trial leadership.
• Contribute to the preparation of regulatory submissions and interactions with FDA, and help ensure regulatory post‑marketing commitments are satisfied with cost‑effective, efficient and scientifically rigorous methods.
• Collaborate with external investigators and thought leaders; develop credible relationships with key opinion leaders, medical societies and patient advocacy organizations across the mood and psychiatry community.
• Partner with the Spravato Medical Director to ensure future indications are supported.
• Take on special projects as needed.

• MD, DO, PhD, PharmD or NP degree required, (PhD Preferred)
• At least 8 years of combined industry, academic, clinical research or clinical practice experience, of which at least 3 years in the pharmaceutical industry with accountability for the timely execution of key deliverables.
• Neuroscience, psychiatry and/or mood‑disorder therapeutic‑area expertise is essential.
• Familiarity with clinical trial design and clinical data interpretation is important; prior R&D or clinical‑development experience is a plus but not required for this role.
• Excellent analytical and strategic‑thinking aptitude, scientific writing proficiency, and strong organizational, written and verbal communication skills, including impactful scientific oral presentations.
• The ability to work in a matrix environment, collaborating effectively with many cross‑functional partners and leading cross‑functional teams, is essential.
• Other:
  Up to 20% travel (primarily domestic, with limited international) is required. This position is located in Titusville, NJ and follows a hybrid schedule…